Trial intelligence / Profile preview

PK of Oral Contraceptives with Ritonavir in HIV+ Women

NCT02531321Phase 4Terminated

Sponsor
University of Southern California
Start
Aug 2015
Primary completion
Nov 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of avatrombopag, ethinyl estradiol in contraception, sponsored by University of Southern California. Started Aug 2015; status: terminated.

02

Drugs

avatrombopagethinyl estradiol
03

Conditions

contraception

Beyond the preview

Go deeper on NCT02531321.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02531321.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call